News – Page 454 – Endpoints News

After 12 months of digging, Pfizer opts for one of two Voyager capsids for gene therapy

3 years ago

Takeda to pull key hypoparathyroidism drug from the market after years of manufacturing woes

3 years ago

Tiny Vergent seals modest Series B in pursuit of cancer imaging agent

3 years ago

In post-Covid life, Vir looks to stomp out influenza in up to $1B BARDA contract that boosts GSK-allied mAb

3 years ago

Bristol Myers inks protein degrader deal via Celgene team's link to seed-stage biotech

3 years ago

Pfizer’s PARP inhibitor combo treatment passes primary endpoint — but details are slim

3 years ago

Sanofi licenses a preclinical genetic disease drug from an unknown biotech spun out of the NIH

3 years ago

Jeff Marrazzo has found a buzzy new biotech cause to champion. And once again, he's all in

3 years ago

A year and a half after Cellarity raised $123M, the Flagship biotech is back — and it's ready to pick out ...

3 years ago

Father starts lab after intellectual property issues stymie rare disease drug development

3 years ago

Can a smartphone app detect Covid? Pfizer throws down $116M to find out

3 years ago

Big Pharma heavyweights seek tweaks to FDA's clinical outcome assessment guidance

3 years ago

Another warning letter for Lupin as FDA identifies deficiencies at India-based site

3 years ago

Another one bites the dust? FDA warns that emerging Omicron subvariant could make Evusheld obsolete

3 years ago

Insmed plots upcoming med launches built on its first drug lessons and consumer playbook marketing strategies

3 years ago

Roche hires new diagnostics chief from within, ahead of C-suite shake-up

3 years ago

FTC chair Lina Khan pledges to use all tools to investigate PBMs

3 years ago

Mesoblast sends in improved potency assay, looking to resubmit to FDA on acute graft-versus-host disease drug

3 years ago

Startup's gold nanocrystal ALS drug flops a PhII trial, a reminder of the disease's obstacles despite Amylyx OK

3 years ago

Moderna refused to disclose mRNA vaccine technology to China — report

3 years ago

Novo Nordisk touts another once-weekly insulin win; Mereo's board battle heats up again

3 years ago

Scandion's shares fall after oncology biotech reports PhII fail

3 years ago

Updated: AstraZeneca nabs a small rare disease gene therapy player for 667% premium

3 years ago

Myovant board balks as majority owner Sumitomo swoops in with a $2.5B deal to buy them out

3 years ago

First page Previous page 451 452 453454455 456 457 Next page Last page